ASX:COHMedical Equipment
How Do China Reimbursement Cuts Recast Cochlear’s (ASX:COH) Long-Term Margin Story?
Earlier in June 2026, Cochlear lowered its earnings guidance, citing hospital capacity constraints, geopolitical tensions, and reimbursement cuts in China as key headwinds.
This revision has sharpened investor focus on how quickly procedure volumes and profit margins can stabilise in the implantable hearing market.
We’ll now explore how Cochlear’s guidance downgrade, particularly the impact of China reimbursement cuts, affects the company’s broader investment narrative.
Find 10 companies...